Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has maintained a Speculative Buy rating on Tenon Medical (NASDAQ:TNON) but has lowered the price target from $5 to $3.
April 15, 2024 | 3:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Benchmark analyst Bruce Jackson maintains a Speculative Buy on Tenon Medical but lowers the price target from $5 to $3.
The reduction in price target from $5 to $3 by a Benchmark analyst could lead to a negative short-term impact on Tenon Medical's stock price. This adjustment reflects a change in the analyst's valuation of the company, which could influence investor sentiment and market perception of the company's future financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100